The House Energy and Commerce Health Subcommittee today opened a two-day hearing on 25 bills designed to address the opioid crisis. Witnesses from the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration outlined steps their agencies are taking to address the epidemic. Witnesses from The Kennedy Forum, Community Anti-Drug Coalitions of America, Biotechnology Innovation Organization, Association for Accessible Medicines, and DisposeRx also testified. AHA is weighing in on the bills with the committee. Chairmen of the relevant committees in Congress have said they hope to enact comprehensive legislation by Memorial Day. The subcommittee hearing will continue tomorrow with testimony from additional witnesses. 

Related News Articles

Headline
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…
Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
U.S. overdose death rates linked to synthetic opioids increased more than 45 percent in 2017, likely driven by illicitly manufactured fentanyl, according to a…
Headline
The Health Resources and Services Administration recently launched a program to provide eligible health care clinicians with student loan repayment assistance…
Insights and Analysis
Also in this weekly roundup of health care news: how mandated access to at-home palliative care has made all the difference for some patients; and a town’s…